Open Access

High expression of RACK1 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma

  • Authors:
    • Hailin Han
    • Dongmei Wang
    • Maowu Yang
    • Shenhao Wang
  • View Affiliations

  • Published online on: December 6, 2017     https://doi.org/10.3892/ol.2017.7539
  • Pages: 2073-2078
  • Copyright: © Han et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Receptor for activated C kinase 1 (RACK1) is associated with certain aspects of cancer biology and signaling pathways, but its function in pancreatic ductal adenocarcinoma (PDAC) remains unknown. In the present study, 157 patients with PDAC were enrolled. RACK1 mRNA and protein expression levels were analyzed in PDAC tissues and matched adjacent noncancerous tissues by reverse transcription‑quantitative polymerase chain reaction and western blotting. RACK1 expression levels in paraffin‑embedded PDAC tissues were determined by immunohistochemistry. The associations between RACK1 expression and clinical data were evaluated using χ2 analysis. The relationship between RACK1 expression and the survival data of patients was analyzed using Kaplan‑Meier and log rank tests. RACK1 mRNA and protein were revealed to be overexpressed in PDAC tumor tissues compared with adjacent noncancerous tissues. RACK1 expression was associated with clinical stage (P=0.001), lymph node invasion (P=0.003) and liver metastasis (P=0.001). Furthermore, patients with PDAC and high RACK1 expression demonstrated shorter overall survival times compared with patients with low RACK1 expression (P=0.002). Multivariate analysis indicated that RACK1 overexpression was an independent prognostic factor for patients with PDAC. Overexpression of RACK1 may contribute to tumor progression, and may be a potential prognostic biomarker for patients with PDAC.
View Figures
View References

Related Articles

Journal Cover

February-2018
Volume 15 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Han H, Wang D, Yang M and Wang S: High expression of RACK1 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma. Oncol Lett 15: 2073-2078, 2018
APA
Han, H., Wang, D., Yang, M., & Wang, S. (2018). High expression of RACK1 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma. Oncology Letters, 15, 2073-2078. https://doi.org/10.3892/ol.2017.7539
MLA
Han, H., Wang, D., Yang, M., Wang, S."High expression of RACK1 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma". Oncology Letters 15.2 (2018): 2073-2078.
Chicago
Han, H., Wang, D., Yang, M., Wang, S."High expression of RACK1 is associated with poor prognosis in patients with pancreatic ductal adenocarcinoma". Oncology Letters 15, no. 2 (2018): 2073-2078. https://doi.org/10.3892/ol.2017.7539